Thermo Fisher Scientific Stock Jumps As Q1 Earnings Surpass Consensus

  • Thermo Fisher Scientific Inc TMO has posted Q1 revenue of $11.82 billion, beating the consensus of $10.63 billion.
  • Organic revenue growth was 3%, acquisitions increased revenue by 18%, and currency translation decreased revenue by 2%. 
  • Core organic growth was 16%. COVID-19 testing revenue was $1.68 billion.
  • Revenue from Life Sciences Solutions Segment remained almost stagnant at $4.2 billion. Analytical Instruments Segment sales were up 9.4% to $1.52 billion. Specialty Diagnostics Segment revenues decreased 8.2% to $1.48 billion, and Laboratory Products and Biopharma Services segment sales were up 51.3% to $5.44 billion.
  • Adjusted EPS of $7.25 topped the consensus of $6.18.
  • Adjusted operating margin contracted from 35.4% a year ago to 29.2%.
  • Thermo Fisher repurchased $2.0 billion of stock and increased its dividend by 15% during the quarter.
  • Price Action: TMO shares are up 6.06% at $552.00 during the premarket session on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: BiotechEarningsLarge CapNewsHealth CareMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!